Reduced DNA topoisomerase II activity in ataxia-telangiectasia cells.
Considerable evidence supports a defect at the level of chromatin structure or recognition of that structure in cells from patients with the human genetic disorder ataxia-telangiectasia. Accordingly, we have investigated the activities of enzymes that alter the topology of DNA in Epstein Barr Virus-transformed lymphoblastoid cells from patients with this syndrome. Reduced activity of DNA topoisomerase II, determined by unknotting of P4 phage DNA, was observed in partially purified extracts from 5 ataxia-telangiectasia cell lines. The levels of enzyme activity was reduced substantially in 4 of these cell lines and to a lesser extent in the other cell line compared to controls. DNA topoisomerase I, assayed by relaxation of supercoiled DNA, was found to be present at comparable levels in both cell types. Reduced activity of topoisomerase II in ataxia-telangiectasia is compatible with the molecular, cellular and clinical changes described in this syndrome.
Singh
S P
SP
Department of Biochemistry, University of Queensland, St Lucia, Brisbane.
Mohamed
R
R
Salmond
C
C
Lavin
M F
MF
D001260:Ataxia Telangiectasia / Q000201:enzymology*; D002461:Cell Line, Transformed; D004264:DNA Topoisomerases, Type I / Q000302:isolation & purification / Q000378:metabolism; D004250:DNA Topoisomerases, Type II / Q000302:isolation & purification / Q000378:metabolism*; D004854:Herpesvirus 4, Human / Q000235:genetics; D006801:Humans
D004264:DNA Topoisomerases, Type I; D004250:DNA Topoisomerases, Type II